Ress et al observed an elevation of hepatic APOA5 mRNA in obese patients with NAFLD, which were markedly down-regulated after improvement in hepatosteatosis [10]. The gene discussed is APOA5; the disease is metabolic dysfunction-associated steatotic liver disease.